Proteinuria as a predictor of total plasma homocysteine levels in type 2 diabetic nephropathy

Diabetes Care

Volumn 25, Issue 11, 2002, Pages 2037-2041

  Friedman, Allon N ^a,b   Hunsicker, Lawrence G ^c   Selhub, Jacob ^a   Bostom, Andrew G ^a,d  

^a TUFTS UNIVERSITY   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d RHODE ISLAND HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE; CYANOCOBALAMIN; FOLIC ACID; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; IRBESARTAN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTEIN; PYRIDOXAL 5 PHOSPHATE; TRIACYLGLYCEROL;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BONE DENSITY; BONE MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEMOGRAPHY; DIABETIC NEPHROPATHY; FOLIC ACID BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PROTEINURIA; SAMPLE SIZE; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL; BLOOD; FEMALE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; URINE;

CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROTEINURIA;

EID: 0036836084     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.25.11.2037     Document Type: Article

References (38)

1. Kannel W, McGee D: Diabetes mellitus and cardiovascular disease risk factors: the Framingham study. Diabetes Care 2:120-126, 1979
2. Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, Mitch W, Smith SC Jr, Sowers JR: Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 100:1134-1146, 1999
3. Dinneen S, Gerstein H: The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus: a systematic overview of the literature. Arch Intern Med 157:1413-1418, 1997
4. Neil A, Hawkins M, Potok M, Thorogood M, Cohen D, Mann J: A prospective population-based study of microalbuminuria as a predictor of mortality in NIDDM. Diabetes Care 16:996-1003, 1993
5. Miettinen H, Haffner S, Lehto S, Ronnemaa T, Pyorala K, Laakso M: Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects. Stroke 27:2033-2039, 1996
6. Nelson R, Pettitt D, Carraher M, Baird H, Knowler W: Effect of proteinuria on mortality in NIDDM. Diabetes 37:1499-1504, 1988
7. Brown WW, Keane W: Proteinuria and cardiovascular disease. Am J Kidney Dis 38(4 Suppl. 1):8-13, 2001
8. Gerstein HC, Mann JFE, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, Halle JP, Young J, Rashkow A, Joyce C, Nawaz S, Yusuf S: Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 286:421-426, 2001
9. Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group: Effect of intensive diabetes treatment on carotid artery wall thickness in the epidemiology of diabetes interventions and complications. Diabetes 48:383-390, 1999
10. Taniwaki H, Nishizawa Y, Kawagishi T, Ishimura E, Emoto M, Okamura T, Okuno Y, Morii H: Decrease in glomerular filtration rate in Japanese patients with type 2 diabetes is linked to atherosclerosis. Diabetes Care 21:1848-1855, 1998
11. Wirta O, Pasternack A, Mustonen J, Laippala P: Renal and cardiovascular predictors of 9-year total and sudden cardiac mortality in non-insulin-dependent diabetic subjects. Nephrol Dial Transplant 12:2612-2617, 1997
12. Hofmann M, Kohl B, Zumbach M, Borcea V, Bierhaus A, Henkels M, Amiral J, Fiehn W, Ziegler R, Wahl P, Nawroth P: Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM. Diabetes Care 20:1880-1886, 1997
13. Hoogeveen E, Kostense P, Jager A, Heine R, Jakobs C, Bouter L, Donker A, Stehouwer C: Serum homocysteine level and protein intake are related to risk of microalbuminuria: the Hoorn study. Kidney Int 54:203-209, 1998
14. Chico A, Perez A, Cordoba A, Arcelus R, Carreras G, Leiva AD, Gonzalez-Sastre F, Blanco-Vaca F: Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease? Diabetologica 41:684-693, 1998
15. Hultberg B, Agardh C, Agardh E, Lovestram-Adrian M: Poor metabolic control, early age at onset, and marginal folate deficiency are associated with increasing levels of plasma homocysteine in insulin-dependent diabetes mellitus: a five-year follow-up study. Scand J Clin Lab Invest 57:595-600, 1997
16. Hultberg B, Agardh E, Andersson A, Brattstrom L, Isaksson A, Israelsson B, Agardh C: Increased levels of plasma homocysteine are associated with nephropathy, but not severe retinopathy in type I diabetes mellitus. Scand J Clin Lab Invest 51:277-282, 1991
17. Bostom A, Selhub J: Homocysteine and arteriosclerosis: subclinical and clinical disease associations. Circulation 99:2361-2363, 1999
18. Bostom A, Silbershatz H, Rosenberg I, Selhub J, D'Agostino R, Wolf P, Jacques P, Wilson P: Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women. Arch Intern Med 159:1077-1080, 1999
19. Arnadottir M, Hultberg B, Nilsson-Ehle P, Thsell H: The effect of reduced glomerular filtration rate on plasma total homocysteine concentration. Scand J Clin Lab Invest 56:41-46, 1996
20. Wollesen F, Brattstrom L, Refsum H, Ueland P, Berglund L, Berne C: Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus. Kidney Int 55:1028-1035, 1999
21. Smulders Y, Rakic M, Slaats E, Treskes M, Sijbrands E, Odekerken D, Stehouwer C, Silberbusch J: Fasting and post-methionine homocysteine levels in NIDDM. Diabetes Care 22:125-132, 1999
22. Bostom A, Kronenberg F, Jacques P, Kuen E, Ritz E, Konig P, Kraatz G, Lhotta K, Mann J, Muller G, Neyer U, Riegel W, Schwenger V, Riegler P, Selhub J: Proteinuria and plasma total homocysteine levels in chronic renal disease patients with a normal range serum creatinine: critical impact of true glomerular filtration rate. Atherosclerosis 159:219-223, 2001
23. Lewis E, Hunsicker L, Clarke W, Berl T, Pohl M, Lewis J, Ritz E, Atkins R, Rohde R, Raz I, Group CS: Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 345:851-860, 2001
24. Ueland PM, Refsum H, Stabler SP, Malinow MR, Andersson A, Allen RH: Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem 39:1764-1779, 1993
25. Araki A, Sako Y: Determination of free and total homocysteine in human plasma by high performance liquid chromatography with fluorescence detection. J Chromatogr 422:43-52, 1987
26. Shin-Buering Y, Rasshofer R, Endres W: A new enzymatic method for pyridoxal 5′-phosphate determination. J Inherit Metab Dis 4:123-124, 1981
27. Nannipieri M, Rizzo L, Rapuano A, Pilo A, Penno G, Navalesi R: Increased transcapillary escape rate of albumin in microalbuminuric type II diabetic patients. Diabetes Care 18:1-9, 1995
28. Shemesh O, Golbetz H, Kriss J, Myers B: Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int 28:830-838, 1985
29. Brattstrom L, Lindgren A, Israelsson B, Andersson A, Hultberg B: Homocysteine and cysteine: determinants of plasma levels in middle-aged and elderly subjects. J Intern Med 236:633-641, 1994
30. Bostom A, Gohh R, Beaulieu A, Han H, Jacques P, Selhub J, Dworkin L, Rosenberg I: Determinants of fasting plasma total homocysteine levels among chronic renal stable renal transplant recipients. Transplantation 68:257-261, 1999
31. Friedman A, Bostom A, Selhub J, Levey A, Rosenberg I: The kidney and homocysteine metabolism. J Am Soc Nephrol 12:2181-2189, 2001
32. Lussier-Cacan S, Xhignesse M, Piolot A, Selhub J, Davignon J, Genest J: Plasma total homocysteine in healthy subjects: sex-specific relation with biological traits. Am J Clin Nutr 64:587-593, 1996
33. Selhub J, Jacques P, Wilson P, Rush D, Rosenberg I: Vitamin-status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 270:2693-2698, 1993
34. Nedrebo B, Ericsson U, Nygard O, Refsum H, Ueland P, Aakvaag A, Aanderud S, Lien E: Plasma total homocysteine levels in hyperthyroid and hypothyroid patients. Metabolism 47:89-93, 1998
35. Passaro A, D'Elia K, Pareschi P, Calzoni F, Carantoni M, Fellin R, Solini A: Factors influencing plasma homocysteine levels in type 2 diabetes. Diabetes Care 23:420-421, 2000
36. Drzewoski J, Czupryniak L, Chwatko G, Bald E: Hyperhomocysteinemia in poorly controlled type 2 diabetes patients. Diabetes Nutr Metab 13:316-324, 2000
37. Kark J, Selhub J, Bostom A, Adler B, Rosenberg I: Plasma homocysteine and all-cause mortality in diabetes. Lancet 253:1936-1937, 1999
38. Pavia C, Ferrer I, Valls C, Artuch R, Colome C, Vilaseca A: Total homocysteine in patients with type 1 diabetes. Diabetes Care 23:84-87, 2000